A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase II, multicenter, randomized, controlled, open-label trial of the safety and
efficacy of Nutropin AQ administered subcutaneously (SC) daily in prepubertal children with
CF and growth restriction.